Medical and Pharmaceutical Scottish study finds biomarker blood biopsy testing can reduce lung cancer fatalities by 40% It was completed by the University of St Andrews and published in the PLOS One journal on Wednesday Rowan DunneJanuary 9, 2025
Medical and Pharmaceutical Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients The biopharma operator's 'HT-001" drug was highly successful in alleviating skin issues caused by a cancer treatment Rowan DunneJanuary 7, 2025
AI and Autonomy Predictive Oncology shares rise 71% as takeover by Renovaro is announced Both companies are focused on AI-powered drug discovery Rowan DunneJanuary 6, 2025
Medical and Pharmaceutical Roche secures rights to Chinese biotech company’s small cell lung cancer drug Innovent Biologics will receive up to US$1 billion in milestone payments and royalties Rowan DunneJanuary 3, 2025
Medical and Pharmaceutical Russia develops mRNA cancer vaccine for citizens, skepticism lingers An absence of data has rendered the announcement questionable Rowan DunneJanuary 2, 2025
AI and Autonomy The Best of 2024: A Mugglehead roundup The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors Joseph MortonDecember 30, 2024
Medical and Pharmaceutical Portage Biotech soars after initiating proceedings for iOx Therapeutics sale The stock went up by over 185% after the LOI was announced Rowan DunneDecember 17, 2024
Health & Wellness GSK small-cell lung cancer drug gets nod from European Medicines Agency Chinese-based Hansoh Pharma is conducting the trial to evaluate GSK'227 in patients with locally advanced or metastatic solid tumours Joseph MortonDecember 17, 2024
Health & Wellness New blood test capable of screening for over 50 cancers available in Canada The Galleri test works by analyzing DNA fragments shed by cancer cells into the bloodstream Joseph MortonDecember 5, 2024
Medical and Pharmaceutical Janux Therapeutics soars on clinical trial data for prostate cancer treatment candidate For 63 per cent of patients, the cancer was either reduced or kept from worsening Joseph MortonDecember 3, 2024